Clinical and Post-Market
Demonstrate complete regulatory compliance by ensuring your in vitro diagnostic (IVD) device conforms to all applicable global requirements.
Delivering compliant IVD products to global markets
Choose Apotech for clinical compliance you can trust
Before placing an IVD device on the market, manufacturers must demonstrate compliance with all applicable global regulatory requirements including In Vitro Diagnostic Regulation (IVDR), 21 CFR and the UK MDR 2002.
At Apotech, our experienced team can make sure that you are conforming with the appropriate conformity assessment procedures. Working on your behalf, we can help you demonstrate that your IVD device achieves its intended purpose and corresponds to its claimed performance throughout its lifetime.
Trusted by top-tier teams worldwide
Why choose Apotech for IVD clinical and post-market services?
Article 56 (1) of the IVDR states that IVD manufacturers must specify and justify the level of clinical evidence given a device’s characteristics and its intended purpose. Therefore, defining this intended purpose must be considered a key driver behind its overall assessment.
Manufacturers must also ensure that they meet the essential requirements of the Medical Devices Regulations 2002 using data gathered through a performance evaluation.
At Apotech, we can support you during the clinical stages of your IVD development in the following areas:
FAQs on IVD clinical and post-market services
At Apotech, we provide a tailored approach to our IVD clinical and post-market services. We aim to make the process as simple to understand as possible and are always on hand to answer any questions you might have.
Here are some of the questions we get asked most often.
Featured case studies
EU-MDR Technical File Authoring
EU-MDR Technical File Authoring Introduction Medical Technology Client Our client is a leader in high-quality, surgeon-designed, innovative ophthalmic products located in the US with operations globally. These range from Class I through to Class III devices. Apotech Consultants Our consultants take a risk-based approach to improve quality and compliance, and implement practical solutions for your…
A genetic testing kit manufacturer Journey to UKCA Marking with Apotech
Introduction The client In response to the UK’s new post-Brexit regulatory requirements, our client, an innovative genetic testing kit manufacturer, collaborated with Apotech to achieve UKCA marking. This strategic move was aimed at maintaining their market presence in the UK, ensuring uninterrupted access for their cutting-edge products. Types Scope of work Apotech provided end-to-end support…
510(k) Submission
510(k) Submission Introduction Radiographic Dental Imagery Device – Class IIb Our client are a leading manufacturer of radiographic dental imaging systems, based in Europe. Following European success, our client set their sights on the US market. Standards & Tools FDA 21 CFR Part 820 GDPR Word Excel, Powerpoint Scope of work Review of documentation for…